Additional research into the regulation of USP7 could help reveal new pathways modulating the NGN3-USP7 axis during the NGN3 expression window, offering insight into the mechanisms that push pancreatic progenitors towards an endocrine fate, with potential uses for in vitro and in vivo beta-cell generation for diabetes therapy. The gene discussed is USP7; the disease is diabetes mellitus.